KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查 入排置信度 0.98

Efficacy of the Dapivirine Vaginal Ring Accounting for Imperfect Adherence.

Marla J Husnik, Renee Heffron, James P Hughes, Barbra Richardson, Ariane van der Straten, Thesla Palanee-Phillips, Lydia Soto-Torres, Devika Singh, Brenda Gati Mirembe, Edward Livant, Zakir Gaffoor, Leila E Mansoor, Samantha S Siva, Sufia Dadabhai, Flavia Matovu Kiweewa, Jared M Baeten, MTN-020/ASPIRE Study Team

AIDS Behav 28(11) 3873-3882

PMID39158801
PMCIDPMC11530124
DOI10.1007/s10461-024-04463-3
发表日期2024-08-19
入排依据:未发现恶性肿瘤人群证据。
摘要

摘要

Product adherence is critical to obtaining objective estimates of efficacy of pre-exposure prophylactic interventions against HIV-1 infection. With imperfect adherence, intention-to-treat analyses assess the collective effects of complete, sub-optimal and non-adherence, providing a biased and attenuated estimate of the average causal effect of an intervention. Using data from the MTN-020/ASPIRE phase III trial evaluating HIV-1 efficacy of the dapivirine vaginal ring, we conducted per-protocol, and adherence-adjusted causal inference analyses using principal stratification and marginal structural models. We constructed two adherence cut offs of ≥ 0.9 mg (low cutoff) and > 4.0 mg (high cutoff) that represent drug released from the ring over a 28-day period. The HIV-1 efficacy estimate (95% CI) was 30.8% (3.6%, 50.3%) (P = 0.03) from the per-protocol analysis, and 53.6% (16.5%, 74.3%) (P = 0.01) among the highest predicted adherers from principal stratification analyses using the low cutoff. Marginal structural models produced efficacy estimates (95% CIs) ranging from 48.8 (21.8, 66.4) (P = 0.0019) to 56.5% (32.8%, 71.9%) (P = 0.0002). Application of adherence-adjusted causal inference methods are useful in interpreting HIV-1 efficacy in secondary analyses of PrEP clinical trials.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。